Russia Unveils 100% Effective mRNA Cancer Vaccine 'Enteromix'

• Russian scientists announce development of 'Enteromix', an mRNA-based cancer vaccine, claiming 100% effectiveness in experimental applications.
• The Federal Medical and Biological Agency (FMBA) states the vaccine will be administered free of charge to patients already diagnosed with cancer.
• Enteromix works by training the immune system to identify and destroy cancer cells, reducing tumor size by 60-80% or significantly slowing growth in some cases.
• Initially, the vaccine will target colon cancer and is most effective in early-stage cancer, though intermediate-stage patients may also benefit.
• Developed by The Gamaleya National Center of Epidemiology and Microbiology, trials show satisfactory results in preventing tumor formation and spread.